Cresco Labs Inc. (CL.CN)
CAD 1.35
(17.39%)
CAD 1.35
(17.39%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 450.18 Million USD | -14.45% |
| 2022 | 350.08 Million USD | 9.9% |
| 2021 | 318.55 Million USD | 39.66% |
| 2020 | 228.09 Million USD | 131.96% |
| 2019 | 98.33 Million USD | 190.78% |
| 2018 | 33.81 Million USD | 76039.23% |
| 2017 | 44.41 Thousand USD | 3.64% |
| 2016 | 42.85 Thousand USD | 176.55% |
| 2015 | -55.98 Thousand USD | -192.89% |
| 2014 | 60.26 Thousand USD | -71.07% |
| 2013 | 208.32 Thousand USD | -45.25% |
| 2012 | 380.51 Thousand USD | 12.08% |
| 2011 | 339.51 Thousand USD | 0.19% |
| 2010 | 338.88 Thousand USD | -23.15% |
| 2009 | 440.97 Thousand USD | 42.02% |
| 2008 | 310.5 Thousand USD | -53.98% |
| 2007 | 674.72 Thousand USD | 51.91% |
| 2006 | 444.15 Thousand USD | -71.45% |
| 2005 | 1.55 Million USD | 252.62% |
| 2004 | 441.25 Thousand USD | 80.63% |
| 2003 | 244.28 Thousand USD | 86.6% |
| 2002 | 130.91 Thousand USD | 46.31% |
| 2001 | 89.48 Thousand USD | -74.51% |
| 2000 | 350.98 Thousand USD | 41.3% |
| 1999 | 248.4 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 63.04 Million USD | -8.73% |
| 2024 Q2 | 62.39 Million USD | -1.03% |
| 2023 Q3 | 71.9 Million USD | -5.5% |
| 2023 Q4 | 69.08 Million USD | -3.93% |
| 2023 Q2 | 76.08 Million USD | -7.54% |
| 2023 FY | 299.48 Million USD | -14.45% |
| 2023 Q1 | 82.29 Million USD | -9.15% |
| 2022 Q2 | 90.2 Million USD | 4.44% |
| 2022 Q4 | 90.58 Million USD | 9.23% |
| 2022 FY | 350.08 Million USD | 9.9% |
| 2022 Q1 | 86.36 Million USD | 7.71% |
| 2022 Q3 | 82.92 Million USD | -8.06% |
| 2021 Q3 | 81.72 Million USD | -5.12% |
| 2021 Q4 | 80.18 Million USD | -1.88% |
| 2021 FY | 318.55 Million USD | 39.66% |
| 2021 Q1 | 70.78 Million USD | -13.94% |
| 2021 Q2 | 86.13 Million USD | 21.69% |
| 2020 Q4 | 82.24 Million USD | 70.45% |
| 2020 FY | 228.09 Million USD | 131.96% |
| 2020 Q2 | 51.73 Million USD | 3.31% |
| 2020 Q3 | 48.25 Million USD | -6.74% |
| 2020 Q1 | 50.07 Million USD | 49.37% |
| 2019 Q3 | 26.46 Million USD | 28.48% |
| 2019 FY | 98.33 Million USD | 190.78% |
| 2019 Q2 | 20.59 Million USD | 16.08% |
| 2019 Q4 | 33.52 Million USD | 26.68% |
| 2019 Q1 | 17.74 Million USD | 8.41% |
| 2018 Q3 | 65.71 Thousand USD | 1058.9% |
| 2018 Q1 | 11.85 Thousand USD | -46.52% |
| 2018 FY | 33.81 Million USD | 76039.23% |
| 2018 Q4 | 16.37 Million USD | 24811.36% |
| 2018 Q2 | 5670.30 USD | -52.17% |
| 2017 FY | 44.41 Thousand USD | 3.64% |
| 2017 Q3 | 5456.35 USD | -43.38% |
| 2017 Q2 | 9636.94 USD | 38.02% |
| 2017 Q4 | 22.17 Thousand USD | 306.33% |
| 2017 Q1 | 6982.42 USD | -60.25% |
| 2016 Q2 | 10.55 Thousand USD | 37.27% |
| 2016 Q3 | 7817.02 USD | -25.95% |
| 2016 Q4 | 17.56 Thousand USD | 124.71% |
| 2016 FY | 42.85 Thousand USD | 176.55% |
| 2016 Q1 | 7690.10 USD | 109.38% |
| 2015 Q4 | -81.98 Thousand USD | -972.13% |
| 2015 FY | -55.98 Thousand USD | -192.89% |
| 2015 Q3 | 9401.15 USD | 32.89% |
| 2015 Q2 | 7074.22 USD | -32.0% |
| 2015 Q1 | 10.4 Thousand USD | -26.94% |
| 2014 Q3 | 20.2 Thousand USD | 22.52% |
| 2014 Q1 | 16.12 Thousand USD | -78.22% |
| 2014 FY | 60.26 Thousand USD | -71.07% |
| 2014 Q4 | 14.24 Thousand USD | -29.5% |
| 2014 Q2 | 16.48 Thousand USD | 2.26% |
| 2013 Q3 | 53.17 Thousand USD | -4.54% |
| 2013 Q2 | 55.7 Thousand USD | 17.34% |
| 2013 FY | 208.32 Thousand USD | -45.25% |
| 2013 Q1 | 47.47 Thousand USD | -68.07% |
| 2013 Q4 | 74.03 Thousand USD | 39.23% |
| 2012 FY | 380.51 Thousand USD | 12.08% |
| 2012 Q3 | 71.42 Thousand USD | 43.11% |
| 2012 Q2 | 49.91 Thousand USD | -56.29% |
| 2012 Q1 | 114.19 Thousand USD | 17.81% |
| 2012 Q4 | 148.68 Thousand USD | 108.15% |
| 2011 Q2 | 123.88 Thousand USD | 117.82% |
| 2011 Q1 | 56.87 Thousand USD | -84.56% |
| 2011 Q3 | 62.77 Thousand USD | -49.33% |
| 2011 Q4 | 96.92 Thousand USD | 54.4% |
| 2011 FY | 339.51 Thousand USD | 0.19% |
| 2010 Q3 | -10 Thousand USD | -111.25% |
| 2010 Q4 | 368.4 Thousand USD | 3780.76% |
| 2010 FY | 338.88 Thousand USD | -23.15% |
| 2010 Q2 | 88.95 Thousand USD | 22.76% |
| 2010 Q1 | 72.45 Thousand USD | -69.31% |
| 2009 Q3 | 72.25 Thousand USD | 1.34% |
| 2009 Q2 | 71.3 Thousand USD | 23.47% |
| 2009 Q1 | 57.74 Thousand USD | 176.06% |
| 2009 FY | 440.97 Thousand USD | 42.02% |
| 2009 Q4 | 236.09 Thousand USD | 226.76% |
| 2008 FY | 310.5 Thousand USD | -53.98% |
| 2008 Q4 | 20.91 Thousand USD | -66.33% |
| 2008 Q2 | 66.89 Thousand USD | -66.95% |
| 2008 Q1 | 202.37 Thousand USD | 1527.59% |
| 2008 Q3 | 62.12 Thousand USD | -7.12% |
| 2007 FY | 674.72 Thousand USD | 51.91% |
| 2007 Q4 | 12.43 Thousand USD | -86.49% |
| 2007 Q3 | 92.06 Thousand USD | -79.21% |
| 2007 Q2 | 442.92 Thousand USD | 503.5% |
| 2007 Q1 | 73.39 Thousand USD | -25.03% |
| 2006 Q3 | 50.24 Thousand USD | -68.76% |
| 2006 Q4 | 97.89 Thousand USD | 94.85% |
| 2006 Q2 | 160.83 Thousand USD | 19.35% |
| 2006 FY | 444.15 Thousand USD | -71.45% |
| 2006 Q1 | 134.75 Thousand USD | 1076.81% |
| 2005 Q3 | 1.27 Million USD | 1662.12% |
| 2005 Q4 | 11.45 Thousand USD | -99.1% |
| 2005 Q2 | 72.17 Thousand USD | -61.08% |
| 2005 Q1 | 185.46 Thousand USD | -1.54% |
| 2005 FY | 1.55 Million USD | 252.62% |
| 2004 FY | 441.25 Thousand USD | 80.63% |
| 2004 Q2 | 33.5 Thousand USD | -66.97% |
| 2004 Q4 | 188.37 Thousand USD | 84.7% |
| 2004 Q1 | 101.43 Thousand USD | 258.89% |
| 2004 Q3 | 101.98 Thousand USD | 204.4% |
| 2003 FY | 244.28 Thousand USD | 86.6% |
| 2003 Q1 | 26.15 Thousand USD | -52.67% |
| 2003 Q2 | 21.82 Thousand USD | -16.55% |
| 2003 Q3 | 164.4 Thousand USD | 653.26% |
| 2003 Q4 | 28.26 Thousand USD | -82.81% |
| 2002 Q1 | 19.52 Thousand USD | 0.0% |
| 2002 FY | 130.91 Thousand USD | 46.31% |
| 2002 Q4 | 55.26 Thousand USD | 127.14% |
| 2002 Q3 | 24.33 Thousand USD | -22.03% |
| 2002 Q2 | 31.2 Thousand USD | 59.84% |
| 2001 FY | 89.48 Thousand USD | -74.51% |
| 2000 FY | 350.98 Thousand USD | 41.3% |
| 1999 FY | 248.4 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -275891.466% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | -3742.449% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -534407.569% |
| The BC Bud Corporation | 1.28 Million CAD | -34989.269% |
| BioNxt Solutions Inc. | 6.73 Million CAD | -6579.802% |
| CordovaCann Corp. | 3.86 Million CAD | -11558.116% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | -10410.66% |
| Captor Capital Corp. | 16.28 Million CAD | -2664.885% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -63692.441% |
| 1CM Inc. | 7.3 Million CAD | -6060.303% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -81499.143% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -9264.074% |
| IM Cannabis Corp. | 22.63 Million CAD | -1888.643% |
| Lobe Sciences Ltd. | 4.13 Million CAD | -10794.625% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -114680.886% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -750215.0% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | -25363.035% |
| Ovation Science Inc. | 54.1 Thousand CAD | -832042.329% |
| Pharmadrug Inc. | 1.33 Million CAD | -33621.694% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -34386.486% |
| RAMM Pharma Corp. | 7.48 Million CAD | -5918.252% |
| RIV Capital Inc. | 21.1 Million CAD | -2033.359% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | -13601.397% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | -1092.254% |
| SLANG Worldwide Inc. | 24.6 Million CAD | -1729.603% |
| 1933 Industries Inc. | 5.12 Million CAD | -8683.759% |
| Red Light Holland Corp. | 2.02 Million CAD | -22181.422% |
| Top Strike Resources Corp. | 3.63 Million CAD | -12295.918% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 146065.268% |
| Adastra Holdings Ltd. | 9.36 Million CAD | -4709.407% |